IGM Biosciences Inc (NAS:IGMS)
$ 12.3 0.91 (7.99%) Market Cap: 729.62 Mil Enterprise Value: 459.23 Mil PE Ratio: 0 PB Ratio: 5.52 GF Score: 34/100

IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 03:30PM GMT
Release Date Price: $22.54 (-9.59%)
Tarun Soni

Good morning, and thank you, everyone, for joining us today. Hope everyone is enjoining -- I hope everyone is enjoying the third day of the conference. My name is Tarun Soni, and I'm a Vice President in JPMorgan's Healthcare Investment Banking group.

(Operator Instructions)

With that, I'm very pleased to introduce you to Fred Schwarzer, CEO of IGM Biosciences. I know he is very excited to tell you a little bit about the story. So without further ado, over to you, Fred.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thanks very much, Tarun. Appreciate the introduction, and we really appreciate the opportunity to present here at the JPMorgan conference. And welcome to all of you, and thanks for taking the time to listen to our presentation. I sincerely wish we were in person, but maybe next year.

So this presentation will contain certain forward-looking statements that are based on information available to IGM Biosciences as of today's date, but we must advise you that these forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot